348 related articles for article (PubMed ID: 20729877)
1. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
Im DS
Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
[TBL] [Abstract][Full Text] [Related]
2. Towards selective lysophospholipid GPCR modulators.
Archbold JK; Martin JL; Sweet MJ
Trends Pharmacol Sci; 2014 May; 35(5):219-26. PubMed ID: 24746475
[TBL] [Abstract][Full Text] [Related]
3. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
5. A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids.
Goetzl EJ; An S
Adv Exp Med Biol; 1999; 469():259-64. PubMed ID: 10667339
[TBL] [Abstract][Full Text] [Related]
6. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
[TBL] [Abstract][Full Text] [Related]
7. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
Chun J; Rosen H
Curr Pharm Des; 2006; 12(2):161-71. PubMed ID: 16454733
[TBL] [Abstract][Full Text] [Related]
8. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
Chun J; Hla T; Lynch KR; Spiegel S; Moolenaar WH
Pharmacol Rev; 2010 Dec; 62(4):579-87. PubMed ID: 21079037
[TBL] [Abstract][Full Text] [Related]
9. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
Meyer zu Heringdorf D; Jakobs KH
Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
[TBL] [Abstract][Full Text] [Related]
10. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
Takuwa Y; Takuwa N; Sugimoto N
J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
[TBL] [Abstract][Full Text] [Related]
11. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.
Goetzl EJ; An S
FASEB J; 1998 Dec; 12(15):1589-98. PubMed ID: 9837849
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of lysophospholipids.
Rivera R; Chun J
Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
[TBL] [Abstract][Full Text] [Related]
13. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate.
Liu S; Paknejad N; Zhu L; Kihara Y; Ray M; Chun J; Liu W; Hite RK; Huang XY
Nat Commun; 2022 Feb; 13(1):731. PubMed ID: 35136060
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
[TBL] [Abstract][Full Text] [Related]
15. Insights into the pharmacological relevance of lysophospholipid receptors.
Mutoh T; Rivera R; Chun J
Br J Pharmacol; 2012 Feb; 165(4):829-44. PubMed ID: 21838759
[TBL] [Abstract][Full Text] [Related]
16. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
Kranenburg O; Moolenaar WH
Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.
Lee H; Goetzl EJ; An S
Am J Physiol Cell Physiol; 2000 Mar; 278(3):C612-8. PubMed ID: 10712250
[TBL] [Abstract][Full Text] [Related]
18. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor.
Goetzl EJ; Kong Y; Kenney JS
Proc Assoc Am Physicians; 1999; 111(3):259-69. PubMed ID: 10354366
[TBL] [Abstract][Full Text] [Related]
19. Bioactive lysophospholipids and their G protein-coupled receptors.
Moolenaar WH
Exp Cell Res; 1999 Nov; 253(1):230-8. PubMed ID: 10579925
[TBL] [Abstract][Full Text] [Related]
20. 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.
Blaho VA; Chun J
Trends Pharmacol Sci; 2018 Nov; 39(11):953-966. PubMed ID: 30343728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
